Cite
APA Citation
Hallakou‐Bozec, S., Vial, G., Kergoat, M., Fouqueray, P., Bolze, S., Borel, A., Fontaine, E., & Moller, D. E. (2021). mechanism of action of Imeglimin: A novel therapeutic agent for type 2 diabetes. Diabetes, obesity & metabolism, 23(3), 664–673. http://access.bl.uk/ark:/81055/vdc_100122904476.0x00001c